$13.3
Avadel Pharmaceuticals is a drug manufacturers - specialty & generic business based in the US. Avadel Pharmaceuticals shares (AVDL) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $13.57 – an increase of 3.39% over the previous week. Avadel Pharmaceuticals employs 154 staff and has a trailing 12-month revenue of around $95.1 million.
What's in this guide?
Our top picks for where to buy Avadel Pharmaceuticals stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Avadel Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AVDL. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Avadel Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Avadel Pharmaceuticals stock price (NASDAQ: AVDL)
Use our graph to track the performance of AVDL stocks over time.Avadel Pharmaceuticals shares at a glance
Latest market close | $13.57 |
---|---|
52-week range | $9.50 - $19.09 |
50-day moving average | $14.36 |
200-day moving average | $15.33 |
Wall St. target price | $24.60 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-1.09 |
Is it a good time to buy Avadel Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Avadel Pharmaceuticals price performance over time
Historical closes compared with the close of $13.92 from 2024-10-17
1 week (2024-10-11) | 6.10% |
---|---|
1 month (2024-09-19) | 2.35% |
3 months (2024-07-19) | -14.07% |
6 months (2024-04-19) | -19.68% |
1 year (2023-10-19) | 35.54% |
---|---|
2 years (2022-10-19) | 135.14% |
3 years (2021-10-19) | 64.54% |
5 years (2019-10-18) | 287.74% |
Is Avadel Pharmaceuticals stock undervalued or overvalued?
Valuing Avadel Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avadel Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Avadel Pharmaceuticals's PEG ratio
Avadel Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.07. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Avadel Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Avadel Pharmaceuticals financials
Revenue TTM | $95.1 million |
---|---|
Gross profit TTM | $16.6 million |
Return on assets TTM | -34.45% |
Return on equity TTM | -99.52% |
Profit margin | -111.64% |
Book value | $0.73 |
Market Capitalization | $1.3 billion |
TTM: trailing 12 months
Avadel Pharmaceuticals share dividends
We're not expecting Avadel Pharmaceuticals to pay a dividend over the next 12 months.
Avadel Pharmaceuticals share price volatility
Over the last 12 months, Avadel Pharmaceuticals's shares have ranged in value from as little as $9.5 up to $19.09. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avadel Pharmaceuticals's is 1.632. This would suggest that Avadel Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Avadel Pharmaceuticals overview
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. .
Frequently asked questions
nullWhat percentage of Avadel Pharmaceuticals is owned by insiders or institutions?
Currently 4.774% of Avadel Pharmaceuticals shares are held by insiders and 79.529% by institutions. How many people work for Avadel Pharmaceuticals?
Latest data suggests 154 work at Avadel Pharmaceuticals. When does the fiscal year end for Avadel Pharmaceuticals?
Avadel Pharmaceuticals's fiscal year ends in December. Where is Avadel Pharmaceuticals based?
Avadel Pharmaceuticals's address is: 10 Earlsfort Terrace, Dublin, Ireland, 2 What is Avadel Pharmaceuticals's ISIN number?
Avadel Pharmaceuticals's international securities identification number is: US05337M1045 What is Avadel Pharmaceuticals's CUSIP number?
Avadel Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 338488109
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question